BioMed
Meredith Wadman traces how human cell cultures enabled the rubella vaccine, alongside the consent failures that shaped its development.
When medicines were built partly on exploited people, that history cannot be removed. The knowledge gained from them is woven into the product. The author's answer is that we should still use them. Their value does not cancel the wrong, and the wrong does not cancel their value.
A working vaccine does not just treat cases. It can remove a disease from a population altogether. The vaccine against the rubella virus, which causes German measles, ended native spread of the disease across the Western Hemisphere. That is why vaccine work can be one of the most productive things a researcher can do.
Once biology became profitable, questions arose that no one had settled, such as who owns a research cell line and who gets the money from inventions built on it. Scientists who once worked for knowledge began selling patents to companies. That set off resentment, lawsuits and clashes between labs, funders and government.
A virus that gives an adult only a light rash can wreck a developing fetus, attacking its brain, eyes, ears and heart. The danger hides because the mother barely feels sick, so a whole epidemic can leave tens of thousands of damaged babies before anyone grasps how the harm happens.
Vaccines are grown in living cells, so the quality of those cells sets the safety of every dose. A single line of clean, well-characterized human cells could become the standard factory for vaccines against many diseases. Strains derived from one such line came to be used in making most human virus vaccines.
An agency that approves products tends to back the method it already knows, even when a new one may be cleaner. The vaccine regulator kept supporting vaccines grown in monkey cells because it was used to them, so the human-cell alternative was sidelined for years.
Before consent rules and ethics boards existed, researchers tested experimental vaccines on people who could not refuse. These included orphans, prisoners, poor patients and institutionalized, intellectually disabled children. Researchers felt justified because the vaccines had passed animal tests.
Scientists who saw themselves as heroes in a quest against disease were ambitious, well funded and got results. That same sense of mission bred confidence that their products were safe enough to try on people. The drive that produced the breakthroughs also produced the ethical lapses.
Research materials can come from a person who is never credited or asked. Here it was a woman whose fetal tissue became cells used in vaccines that protected more than 150 million people. The source of the material vanishes from the story while the material itself saves lives.
Normal cells grown in the lab do not divide forever. They stop after a set number of divisions and die. This limit challenged the belief of the time that cultured cells could live indefinitely, and it suggested that aging happens at the level of single cells.